Neuronostics
Neuronostics is a startup headquartered in Bristol, United Kingdom, founded in 2017. It has won about £849k in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Neuronostics has won about £849k in competitive Innovate UK grants since 2023.
- BioEP for prognosis: A quantitative biomarker for measuring response to anti-seizure medications (£500k, 2024)
- Determining the clinical utility of BioEP: a multisite, prospective, study (£349k, 2024)
R&D ecosystem
Neuronostics sits inside the Bristol region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Bristol
Related
- Innovation profile of Bristol
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Neuronostics do?
Neuronostics works in deep tech research. Its Innovate UK projects include: BioEP for prognosis: A quantitative biomarker for measuring response to anti-seizure medications.
Where is Neuronostics based?
Neuronostics is headquartered in Bristol, United Kingdom.
When was Neuronostics founded?
Neuronostics was founded in 2017.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.